The role of platelet von Willebrand factor in platelet adhesion and thrombus formation: a study of 34 patients with various subtypes of type I von Willebrand disease
- PMID: 8199022
- DOI: 10.1111/j.1365-2141.1994.tb04734.x
The role of platelet von Willebrand factor in platelet adhesion and thrombus formation: a study of 34 patients with various subtypes of type I von Willebrand disease
Abstract
In order to investigate the respective role of plasma and platelet von Willebrand factor (vWF) in mediating platelet adhesion and thrombus formation, we performed ex vivo perfusion studies with native blood from patients with various subtypes of type I von Willebrand disease (vWD). We studied 34 patients with type I vWD (19 'platelet normal', five 'platelet low', two 'platelet discordant', eight 'Vicenza'). Parallel studies were carried out on nine patients with severe vWD (type III). At high shear rate (2600 s-1) we found that the defect in platelet-vessel wall interactions in patients having a normal platelet vWF content ('platelet normal' and 'Vicenza') involved thrombus formation, whereas platelet adhesion was normal. At this high shear rate, platelet adhesion and thrombus volume were significantly decreased in patients with subtypes 'platelet low' and 'platelet discordant', i.e. when platelet vWF is either low or dysfunctional. These results indicate that platelet vWF may substitute for plasma vWF to promote platelet adhesion, emphasizing the important role of platelet vWF. They also confirm the role of vWF in thrombus formation at high shear rate because an abnormal thrombus volume was observed in all patients, even when platelet adhesion was normal.
Similar articles
-
In vivo experiments indicate that relatively high platelet deposition in von Willebrand's disease 'Vicenza' is caused by normal platelet-VWF levels rather than by high VWF-multimers in plasma.Thromb Res. 1992 Jan 15;65(2):221-8. doi: 10.1016/0049-3848(92)90242-3. Thromb Res. 1992. PMID: 1579897
-
Ex vivo experimental thrombosis in variants of von Willebrand disease.C R Acad Sci III. 1993 Oct;316(10):1260-5. C R Acad Sci III. 1993. PMID: 8062135
-
Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.J Clin Invest. 1985 Feb;75(2):531-40. doi: 10.1172/JCI111729. J Clin Invest. 1985. PMID: 3919060 Free PMC article.
-
Interaction of the von Willebrand factor with platelets and thrombosis.Recenti Prog Med. 1997 Nov;88(11):526-9. Recenti Prog Med. 1997. PMID: 9401429 Review.
-
von Willebrand factor and the blood vessel wall.Mayo Clin Proc. 1991 Jun;66(6):628-33. doi: 10.1016/s0025-6196(12)60523-0. Mayo Clin Proc. 1991. PMID: 2046402 Review.
Cited by
-
How I manage severe von Willebrand disease.Br J Haematol. 2019 Nov;187(4):418-430. doi: 10.1111/bjh.16186. Epub 2019 Sep 9. Br J Haematol. 2019. PMID: 31498884 Free PMC article. Review.
-
Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report.Haemophilia. 2013 Mar;19 Suppl 3(0 3):1-18. doi: 10.1111/hae.12078. Haemophilia. 2013. PMID: 23383607 Free PMC article.
-
The impact of von Willebrand factor on fibrin formation and structure unveiled with type 3 von Willebrand disease plasma.Blood Coagul Fibrinolysis. 2024 Jul 1;35(5):256-264. doi: 10.1097/MBC.0000000000001309. Epub 2024 May 20. Blood Coagul Fibrinolysis. 2024. PMID: 38973517 Free PMC article.
-
Platelet von Willebrand factor in inherited and acquired bleeding disorders.Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2428-32. doi: 10.1073/pnas.92.7.2428. Proc Natl Acad Sci U S A. 1995. PMID: 7708659 Free PMC article. Review. No abstract available.
-
Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease.PLoS One. 2016 Aug 17;11(8):e0161310. doi: 10.1371/journal.pone.0161310. eCollection 2016. PLoS One. 2016. PMID: 27532107 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous